Development of an enteric-coated formulation containing freeze-dried, viable recombinant Lactococcus lactis for the ileal mucosal delivery of human interleukin-10
- Author
- Nathalie Huyghebaert, A VERMEIRE, S NEIRYNCK, Lothar Steidler (UGent) , Erik Remaut (UGent) and Jean Paul Remon (UGent)
- Organization
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 189.00 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-320679
- MLA
- Huyghebaert, Nathalie, et al. “Development of an Enteric-Coated Formulation Containing Freeze-Dried, Viable Recombinant Lactococcus Lactis for the Ileal Mucosal Delivery of Human Interleukin-10.” EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, vol. 60, no. 3, Elsevier Science, 2005, pp. 349–59, doi:10.1016/j.ejpb.2005.02.012.
- APA
- Huyghebaert, N., VERMEIRE, A., NEIRYNCK, S., Steidler, L., Remaut, E., & Remon, J. P. (2005). Development of an enteric-coated formulation containing freeze-dried, viable recombinant Lactococcus lactis for the ileal mucosal delivery of human interleukin-10. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 60(3), 349–359. https://doi.org/10.1016/j.ejpb.2005.02.012
- Chicago author-date
- Huyghebaert, Nathalie, A VERMEIRE, S NEIRYNCK, Lothar Steidler, Erik Remaut, and Jean Paul Remon. 2005. “Development of an Enteric-Coated Formulation Containing Freeze-Dried, Viable Recombinant Lactococcus Lactis for the Ileal Mucosal Delivery of Human Interleukin-10.” EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS 60 (3): 349–59. https://doi.org/10.1016/j.ejpb.2005.02.012.
- Chicago author-date (all authors)
- Huyghebaert, Nathalie, A VERMEIRE, S NEIRYNCK, Lothar Steidler, Erik Remaut, and Jean Paul Remon. 2005. “Development of an Enteric-Coated Formulation Containing Freeze-Dried, Viable Recombinant Lactococcus Lactis for the Ileal Mucosal Delivery of Human Interleukin-10.” EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS 60 (3): 349–359. doi:10.1016/j.ejpb.2005.02.012.
- Vancouver
- 1.Huyghebaert N, VERMEIRE A, NEIRYNCK S, Steidler L, Remaut E, Remon JP. Development of an enteric-coated formulation containing freeze-dried, viable recombinant Lactococcus lactis for the ileal mucosal delivery of human interleukin-10. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS. 2005;60(3):349–59.
- IEEE
- [1]N. Huyghebaert, A. VERMEIRE, S. NEIRYNCK, L. Steidler, E. Remaut, and J. P. Remon, “Development of an enteric-coated formulation containing freeze-dried, viable recombinant Lactococcus lactis for the ileal mucosal delivery of human interleukin-10,” EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, vol. 60, no. 3, pp. 349–359, 2005.
@article{320679, author = {{Huyghebaert, Nathalie and VERMEIRE, A and NEIRYNCK, S and Steidler, Lothar and Remaut, Erik and Remon, Jean Paul}}, issn = {{0939-6411}}, journal = {{EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS}}, language = {{eng}}, number = {{3}}, pages = {{349--359}}, publisher = {{Elsevier Science}}, title = {{Development of an enteric-coated formulation containing freeze-dried, viable recombinant Lactococcus lactis for the ileal mucosal delivery of human interleukin-10}}, url = {{http://doi.org/10.1016/j.ejpb.2005.02.012}}, volume = {{60}}, year = {{2005}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: